Lin Shen

61PUBLICATIONS
189CO-AUTHORS
Genomics and transcriptomicsChemotherapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (61)

|Sep 07, 2026
Enhancing pan-cancer spatial transcriptomics at single-cell resolution with stPainter.

|Aug 24, 2026
EMB-01, an Anti-EGFR/c-MET Bispecific Antibody, in Patients with Heavily Pretreated Metastatic Colorectal Cancer From a Phase Ib/II, Open-Label, Multicenter Study.

|Jul 15, 2026
Tinengotinib (TT-00420) inhibits tumor growth and overcomes multidrug resistance in gastrointestinal cancers.

|Jul 11, 2026
Genomic analysis of oesophageal carcinoma (EC) identifies recurrent mutations in histone methyltransferases as a distinctive subset.

|Jun 23, 2026
Efficacy and safety of infigratinib in patients with refractory advanced gastric or gastroesophageal junction adenocarcinoma harboring FGFR2 gene amplification: a single-arm, multicenter phase 2 trial.

|Jun 13, 2026
Surufatinib plus toripalimab for patients with advanced solid tumors and disease progression after prior immunotherapy: an open-label multi-cohort phase 2 trial.

Pageof 11

Frequent Collaborators

12 joint publications

Jian Li

9 joint publications

Changsong Qi

6 joint publications

Cheng Zhang

5 joint publications

Jiajia Yuan